HomeAI · summaries
Storia in 7 fonti
Why Is Bio-Techne Stock Soaring Thursday? - Bio-Techne (NASDAQ:TECH), MERCK KGAA by Merck KGaA (OTC:MKGAF
Merck KGaA is acquiring Bio-Techne in an $11.3B all-cash deal to expand its life science, diagnostics, and bioprocessing footprint.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
wiwo.de
Bio-Techne: Merck kauft Bio-Techne für 11,3 Milliarden Dollar
Der Darmstädter Merck-Konzern kauft den US-Laborausrüster Bio-Techne für 11,3 Milliarden Dollar. Der Deal stärkt das Life-Science-Geschäft und verspricht Synergien.
- ·
cnbc.com
Germany's Merck to buy Bio-Techne for $11.3 billion
Merck KGaA has agreed to acquire biotech firm Bio-Techne for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
